Stories tagged 'VIDD'
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
May 17, 2019 | By Sabin Russell / Fred Hutch News Service
A Hutch team led by Dr. Justin Taylor shows that B cells, which are crucial components of the immune system, can be genetically engineered to make exactly the antibodies we want. It could lead to a potentially more precise and dependable way to generate protection without vaccines.
Good News at Fred Hutch
Celebrating faculty and staff achievements
July 20, 2017
CBS'Sunday Morning" features Dr. Jim Olson's tumor paint research, Hutch researchers received HIV cure research grants to investigate approaches to overcoming the main barrier to an HIV cure: reducing reservoirs of virus that lie dormant in some of the longest-lived cells of the body.grants.
Tags: biostatistics, Clinical Research, D. Gary Gilliland, defeatHIV, Florian Hladik, Garnet Anderson, Hans-Peter Kiem, hiv, hiv cure, Jim Olson, Joshua Schiffer, Keith Jerome, Public Health Sciences, Suresh Moolgavkar, Timothy Ray Brown, tumor paint, Vaccine and Infectious Disease, Vaccine development - Viral cancers, VIDD
Nov. 21, 2016
To highlight the breadth new discoveries about the human microbiome, here is a snapshot of just five recent surprising and important findings that may affect your health.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Is it possible to prevent breast cancer metastasis?
Could a simple blood test replace the invasive tissue biopsy?
GIVE NOW &
SAVE LIVES
Story Archive
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
